BRPI0818339A2 - Produto de dispersão sólida contendo composto à base de n-aril uréia - Google Patents

Produto de dispersão sólida contendo composto à base de n-aril uréia

Info

Publication number: BRPI0818339A2
Authority: BR; Brazil
Prior art keywords: product containing; solid dispersion; urea compound; dispersion product; aryl urea
Prior art date: 2007-10-19

Application number

Other languages

English (en)

Inventor

Rudolf Schroeder

Tanja Heitermann

Original Assignee

Abbott Gmbh & Co Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-19

Filing date

2008-10-17

Publication date

2015-04-22

2008-10-17 Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg

2015-04-22 Publication of BRPI0818339A2 publication Critical patent/BRPI0818339A2/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

BRPI0818339 2007-10-19 2008-10-17 Produto de dispersão sólida contendo composto à base de n-aril uréia BRPI0818339A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US99961307P	2007-10-19	2007-10-19
PCT/EP2008/064073 WO2009050289A2 (en)	2007-10-19	2008-10-17	Solid dispersion product containing n-aryl urea-based compound

Publications (1)

Publication Number	Publication Date
BRPI0818339A2 true BRPI0818339A2 (pt)	2015-04-22

Family

ID=40089072

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0818339 BRPI0818339A2 (pt)	2007-10-19	2008-10-17	Produto de dispersão sólida contendo composto à base de n-aril uréia

Country Status (23)

Country	Link
US (1)	US20090143423A1 (pt)
EP (1)	EP2197426A2 (pt)
JP (1)	JP2011500647A (pt)
KR (1)	KR20100090689A (pt)
CN (1)	CN101827585A (pt)
AR (1)	AR068916A1 (pt)
AU (1)	AU2008313620A1 (pt)
BR (1)	BRPI0818339A2 (pt)
CA (1)	CA2699335A1 (pt)
CL (1)	CL2008003092A1 (pt)
CO (1)	CO6270303A2 (pt)
CR (1)	CR11441A (pt)
DO (1)	DOP2010000114A (pt)
EC (1)	ECSP10010184A (pt)
GT (1)	GT201000095A (pt)
MX (1)	MX2010004292A (pt)
PE (1)	PE20091041A1 (pt)
RU (1)	RU2010119924A (pt)
TW (1)	TW200922549A (pt)
UA (1)	UA100866C2 (pt)
UY (1)	UY31406A1 (pt)
WO (1)	WO2009050289A2 (pt)
ZA (1)	ZA201002130B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX2011004090A (es) *	2008-10-17	2011-05-31	Abbott Lab	Antagonistas trpv1.
AR073631A1 (es) *	2008-10-17	2010-11-17	Abbott Lab	Antagonistas del receptor transitorio potencial de vanilloides 1 ( trpv1) utiles para tratar inflamacion y dolor
US20100210682A1 (en) *	2009-02-19	2010-08-19	Abbott Laboratories	Repeated Dosing of TRPV1 Antagonists
WO2011032860A1 (de) *	2009-09-18	2011-03-24	Basf Se	Verfahren zur herstellung von zubereitungen von in wasser schwerlöslichen substanzen
US10463739B2 (en) *	2010-12-23	2019-11-05	AbbVie Deutschland GmbH & Co. KG	Solid retard formulations based on solid dispersions
JP2014505054A (ja) *	2011-01-10	2014-02-27	セルジーンコーポレイション	シクロプロパンカルボン酸｛２−［（１ｓ）−１−（３−エトキシ−４−メトキシ−フェニル）−２−メタンスルホニル−エチル］−３−オキソ−２，３−ジヒドロ−１ｈ−イソインドール−４−イル｝−アミドの経口剤形
WO2013101550A1 (en) *	2011-12-29	2013-07-04	Abbvie Inc.	Solid compositions comprising an hcv inhibitor
US9034832B2 (en)	2011-12-29	2015-05-19	Abbvie Inc.	Solid compositions
TW201431570A (zh)	2012-11-22	2014-08-16	Ucb Pharma Gmbh	用於經皮投服羅替戈汀（Ｒｏｔｉｇｏｔｉｎｅ）之多天式貼片
EP2950786B1 (en)	2013-01-31	2019-11-27	Gilead Pharmasset LLC	Combination formulation of two antiviral compounds
CN105228593B (zh)	2013-03-15	2018-08-28	勃林格殷格翰国际有限公司	呈无定形状态的hcv抑制剂的固体口服剂型
JP6726096B2 (ja)	2013-07-03	2020-07-22	エルテーエスローマンテラピー−システメアーゲー	電子部品を有する経皮治療システム
PT3038601T (pt)	2013-08-27	2020-06-30	Gilead Pharmasset Llc	Formulação combinada de dois compostos antivirais
CA2948219C (en)	2014-05-20	2023-04-04	Lts Lohmann Therapie-Systeme Ag	Method for adjusting the release of active agent in a transdermal delivery system
CN106456566B (zh) *	2014-05-20	2020-06-16	Lts勒曼治疗系统股份公司	含罗替戈汀的经皮递送系统
US11752110B2 (en)	2014-05-20	2023-09-12	Lts Lohmann Therapie-Systeme Ag	Transdermal delivery system including an interface mediator
ES3063790T3 (en)	2015-06-09	2026-04-20	Lonza Sales Ag	Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules
CA3039767C (en) *	2015-12-22	2023-11-14	Arizona Board Of Regents On Behalf Of The University Of Arizona	Compositions and methods for treatment, amelioration, and prevention of anesthesia-induced hypothermia
CN112955130A (zh) *	2018-10-30	2021-06-11	佩洛通治疗公司	包含取代茚满的固体分散体和药物组合物及其制备和使用方法
WO2021039023A1 (ja)	2019-08-23	2021-03-04	持田製薬株式会社	ヘテロシクリデンアセトアミド誘導体の製造方法
PL4019485T3 (pl)	2019-08-23	2024-10-21	Mochida Pharmaceutical Co., Ltd.	Sposób wytwarzania pochodnych heterocyklidenoacetamidu

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5362878A (en) *	1991-03-21	1994-11-08	Pfizer Inc.	Intermediates for making N-aryl and N-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme A: cholesterol acyl transferase (ACAT)
AU4028393A (en) *	1992-05-28	1993-12-30	Pfizer Inc.	New (N)-aryl and (N)-heteroarylurea derivatives as inhibitors of acyl coenzyme a:cholesterol acyl transferase (ACAT)
JP2002520377A (ja) *	1998-07-14	2002-07-09	イーエムインダストリーズインコーポレイテッド	ミクロ分散薬物送達システム
US7015233B2 (en) *	2003-06-12	2006-03-21	Abbott Laboratories	Fused compounds that inhibit vanilloid subtype 1 (VR1) receptor
AR049297A1 (es) *	2004-06-08	2006-07-12	Vertex Pharma	Una composicion farmaceutica y dispersiones solidas de vx-950 (inhibidor de la proteasa de hcv ns3/4a) y proceso de obtencion
ATE395905T1 (de) *	2004-08-27	2008-06-15	Bayer Pharmaceuticals Corp	Pharmazeutische zusammensetzungen in form fester dispersionen zur behandlung von krebs
KR20080042039A (ko) *	2005-04-18	2008-05-14	루비콘 리서치 피브이티. 엘티디.	생물학적으로 강화된 조성물
KR100715355B1 (ko) *	2005-09-30	2007-05-07	주식회사유한양행	프란루카스트를 함유하는 분무-건조 과립 및 그의 제조방법
EP1959926A1 (en) *	2005-10-25	2008-08-27	Abbott Laboratories	Formulation comprising a drug of low water solubility and method of use thereof
WO2007066189A2 (en) *	2005-12-09	2007-06-14	Pfizer Products Inc.	Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea
US7745448B2 (en) *	2005-12-28	2010-06-29	Abbott Laboratories Inc.	Crystalline N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-N′-(2-fluoro-5-(trifluoromethyl)phenyl)urea ethanolate
WO2007092642A2 (en) *	2006-02-09	2007-08-16	Merck & Co., Inc.	Polymer formulations of cetp inhibitors

2008
- 2008-10-17 PE PE2008001785A patent/PE20091041A1/es not_active Application Discontinuation
- 2008-10-17 WO PCT/EP2008/064073 patent/WO2009050289A2/en not_active Ceased
- 2008-10-17 JP JP2010529406A patent/JP2011500647A/ja active Pending
- 2008-10-17 US US12/253,499 patent/US20090143423A1/en not_active Abandoned
- 2008-10-17 BR BRPI0818339 patent/BRPI0818339A2/pt not_active IP Right Cessation
- 2008-10-17 CA CA2699335A patent/CA2699335A1/en not_active Abandoned
- 2008-10-17 KR KR1020107010874A patent/KR20100090689A/ko not_active Withdrawn
- 2008-10-17 AU AU2008313620A patent/AU2008313620A1/en not_active Abandoned
- 2008-10-17 EP EP08840773A patent/EP2197426A2/en not_active Withdrawn
- 2008-10-17 AR ARP080104542A patent/AR068916A1/es not_active Application Discontinuation
- 2008-10-17 UA UAA201006030A patent/UA100866C2/ru unknown
- 2008-10-17 MX MX2010004292A patent/MX2010004292A/es not_active Application Discontinuation
- 2008-10-17 UY UY31406A patent/UY31406A1/es not_active Application Discontinuation
- 2008-10-17 CN CN200880112161A patent/CN101827585A/zh active Pending
- 2008-10-17 RU RU2010119924/15A patent/RU2010119924A/ru not_active Application Discontinuation
- 2008-10-17 TW TW097140229A patent/TW200922549A/zh unknown
- 2008-10-17 CL CL2008003092A patent/CL2008003092A1/es unknown
2010
- 2010-03-25 ZA ZA2010/02130A patent/ZA201002130B/en unknown
- 2010-04-15 GT GT201000095A patent/GT201000095A/es unknown
- 2010-04-16 DO DO2010000114A patent/DOP2010000114A/es unknown
- 2010-04-27 CO CO10049270A patent/CO6270303A2/es not_active Application Discontinuation
- 2010-05-17 EC EC2010010184A patent/ECSP10010184A/es unknown
- 2010-05-19 CR CR11441A patent/CR11441A/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
ZA201002130B (en)	2011-11-30
AU2008313620A1 (en)	2009-04-23
CA2699335A1 (en)	2009-04-23
UY31406A1 (es)	2009-05-29
TW200922549A (en)	2009-06-01
UA100866C2 (ru)	2013-02-11
DOP2010000114A (es)	2010-05-15
WO2009050289A2 (en)	2009-04-23
RU2010119924A (ru)	2011-11-27
CR11441A (es)	2010-10-25
CN101827585A (zh)	2010-09-08
EP2197426A2 (en)	2010-06-23
MX2010004292A (es)	2010-08-02
AR068916A1 (es)	2009-12-16
KR20100090689A (ko)	2010-08-16
JP2011500647A (ja)	2011-01-06
ECSP10010184A (es)	2010-06-29
GT201000095A (es)	2012-04-03
US20090143423A1 (en)	2009-06-04
PE20091041A1 (es)	2009-08-22
WO2009050289A3 (en)	2010-03-25
CO6270303A2 (es)	2011-04-20
CL2008003092A1 (es)	2009-11-27

Publication	Publication Date	Title
BRPI0818339A2 (pt)	2015-04-22	Produto de dispersão sólida contendo composto à base de n-aril uréia
BRPI0818373A2 (pt)	2017-05-16	compostos de pelicetal, síntese e aplicações
EP2168966A4 (en)	2011-02-16	BICYCLOANILINDERIVAT
BRPI0815277A2 (pt)	2015-02-03	"monitores de particulado"
DE112008002590A5 (de)	2010-06-24	Mikroreaktor
BRPI0810898A2 (pt)	2017-05-02	composições agroquímicas
BRPI0815042A2 (pt)	2015-02-10	Compostos de pirazol
MA30307B1 (fr)	2009-04-01	Composes chimiques
PT2430921T (pt)	2017-09-15	Fungicidas de benzeno substituído
RU2493831C3 (ru)	2017-06-08	Фармацевтические композиции
BRPI0813753A2 (pt)	2014-12-30	Produto pré-impregnado
BRPI0806689A2 (pt)	2015-07-21	Compostos químicos 637
DK2966175T3 (da)	2019-07-01	Farmaceutiske sammensætninger indeholdende cortexolon-17-alpha-propionat
HUE037800T2 (hu)	2018-09-28	Gyógyszerkészítmény ektoparaziták leküzdésére
ATE531278T1 (de)	2011-11-15	Süsswaren-produkt
BRPI0811035A2 (pt)	2014-10-21	Composições de fibrina contendo compostos de estrôncio
BRPI0719275A2 (pt)	2014-04-29	Composições de carbamatos de fenil-alquil-amino
BRPI0807078A2 (pt)	2014-04-08	Composto, e, formulação farmacêutica
DE602007013849D1 (de)	2011-05-26	Mikroreaktor
EP2135903A4 (en)	2010-07-21	COATING AGENT
EP1951250A4 (en)	2009-12-16	CHEMICAL COMPOUNDS
BRPI0816450A2 (pt)	2015-03-03	Fungicidas
BRPI0820198A2 (pt)	2019-09-24	composições farmacêuticas
BRPI0814748A2 (pt)	2015-03-03	Compostos de alditóis substituídos, composições e métodos
BRPI0819793A2 (pt)	2015-05-05	Material composto funcional

Legal Events

Date	Code	Title	Description
2015-12-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE AS 6A E 7A ANUIDADES.
2016-04-05	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.